Examination of postoperative nausea and vomiting frequency by using remimazolam

Examination of postoperative nausea and vomiting frequency by using remimazolam - Examination of postoperative nausea and vomiting frequency by using remimazolam

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040944

Enrollment

200

Registered

2020-07-10

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast tumor Gynecological diseases

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Breast tumor Gynecological diseases Patients with ASA PS1, 2

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Postoperative nausea vomiting	—

Countries

Japan

Contacts

Public ContactYumi Obata

St. Marianna University School Dept of Anesthesiology

y2obata@marianna-u.ac.jp044-977-8111

Outcome results